ISRG — Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Company profile
- Sector: Healthcare
- Industry: Medical - Instruments & Supplies
- Country: US
- Exchange: NASDAQ
- Employees: 15,638
- Website: https://www.intuitive.com
Latest SEC filings for ISRG
- 144 — 2026-10-23
- 144 — 2026-10-23
- 144 — 2026-10-23
- 144 — 2026-10-23
- S-8 — 2026-07-21
- 8-K — 2026-07-16
- 8-K — 2026-05-28
- 8-K — 2026-05-04
- 10-Q — 2026-04-22
- 8-K — 2026-04-21
Latest ISRG news
- — FMS Launches multiFiltratePRO System for U.S. Patients With Acute AKI (Zacks Investment Research)
- — Breakfast News: Week in Review (The Motley Fool)
- — New Strong Buy Stocks for October 23rd (Zacks Investment Research)
- — Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (The Motley Fool)
- — Revvity Launches Signals LabGistics to Coordinate Scientific Workflows (Zacks Investment Research)
- — Abbott: 3 Key Takeaways for Long-Term Investors (The Motley Fool)
- — Intuitive Surgical drops as concerns over da Vinci procedure growth overshadow Q3 beat (seekingalpha_market)
- — ISRG Q3 Earnings Call Highlights Pricing and Growth Strategy (Zacks Investment Research)
- — Breakfast News: A $5.7 Billion Flex or Genius? (The Motley Fool)
- — Intuitive narrows 2026 procedure growth outlook to 14%-15% amid I&A pricing actions targeting 3%-5% per-procedure reduction (seekingalpha_market)
Educational tool only — not investment advice.